[Increased rate of glucuronidation in the human and animal newborn by therapeutic doses of phenobarbital].
D000082:Acetaminophen / Q000097:blood / Q000378:metabolism; D000284:Administration, Oral; D000818:Animals; D000831:Animals, Newborn; D001663:Bilirubin / Q000378:metabolism; D001711:Biotransformation / Q000187:drug effects; D002849:Chromatography, Gas; D004790:Enzyme Induction; D005069:Evaluation Studies as Topic; D005260:Female; D005965:Glucuronates / Q000378:metabolism*; D006602:Hexosyltransferases / Q000378:metabolism; D006801:Humans; D007231:Infant, Newborn; D008657:Metabolic Clearance Rate; D010634:Phenobarbital / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011247:Pregnancy; D011817:Rabbits; D013997:Time Factors
D005965:Glucuronates; D000082:Acetaminophen; D006602:Hexosyltransferases; D001663:Bilirubin; D010634:Phenobarbital
Steigerung der Glucuronidierungsrate in der Neugeborenenperiode durch therapeutische Phenobarbitaldosen Klinische und tierexperimentelle Untersuchungen.